Healthcare startup Abridge has raised $300 million Series E at a $5.3 billion valuation, led by Andreessen Horowitz, to enhance revenue cycles and connect clinicians with billing teams.

Jun 24, 2025•6 months ago

Amount Raised

$300 Million

Round Type

SERIES E

San FranciscoArtificial IntelligenceHealth Care

Investors

Khosla VenturesAndreessen Horowitz

Description

Abridge, which leverages AI for medical documentation, has raised $300 million in a Series E round, boosting its valuation to $5.3 billion.. This funding round focuses on improving revenue cycles and clinician-billing team collaboration. The lead investor is Andreessen Horowitz, with Khosla Ventures participating. Abridge is also expanding its partnerships with over 150 U.S

Company Information

Company

Abridge

Location

San Francisco, California, United States

About

Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.

Related People

4 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends